Upgrade to SI Premium - Free Trial

SurModics (SRDX) PT Lowered to $70 at Needham & Company

November 10, 2021 12:10 PM
Needham & Company analyst Mike Matson lowered the price target on SurModics (NASDAQ: SRDX) to $70.00 (from $76.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles